Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2741-2750 of 11890

Edit search filters
  1. Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)

    Rochester, MN

  2. Feasibility Of Autologous Adipose-derived Stromal Cells From Stromal Vascular Fraction (SVF) To Treat Adults With Pressure Ulcers Or Diabetic Foot Ulcers

    Jacksonville, FL

  3. A Phase 3 Safety And Efficacy Study Of Fovista™ (E10030) Intravitreous Administration In Combination With Lucentis® Compared To Lucentis® Monotherapy

    Rochester, MN

  4. A Clinical And Molecular Risk-Directed Therapy For Newly Diagnosed Medulloblastoma

  5. Riluzole In Spinal Cord Injury Study

    Rochester, MN

  6. Safety And Efficacy Of Simtuzumab (GS-6624) In Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary To Non-Alcoholic Steatohepatitis (NASH)

    Scottsdale/Phoenix, AZ

  7. A Study To Evaluate The Efficacy, Safety, And Pharmacokinetics Of Co-Administration Of ABT-493 And ABT-530 With And Without RBV In Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 Or 6 Infection

    Scottsdale/Phoenix, AZ

  8. Study For The Treatment Of Cytomegalovirus (CMV) Infection In Hematopoietic Stem Cell Transplant Recipients

    Rochester, MN

  9. Density MATTERS [Molecular Breast Imaging (MBI) And Tomosynthesis To Eliminate The Reservoir]

    La Crosse, WI, Rochester, MN

  10. Anemia Studies In Chronic Kidney Disease: Erythropoiesis Via A Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)

    Jacksonville, FL

.

Mayo Clinic Footer